Eva-Maria Nichols

536 total citations
11 papers, 246 citations indexed

About

Eva-Maria Nichols is a scholar working on Immunology, Molecular Biology and Nephrology. According to data from OpenAlex, Eva-Maria Nichols has authored 11 papers receiving a total of 246 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Nephrology. Recurrent topics in Eva-Maria Nichols's work include Complement system in diseases (7 papers), Renal Diseases and Glomerulopathies (3 papers) and Inflammasome and immune disorders (3 papers). Eva-Maria Nichols is often cited by papers focused on Complement system in diseases (7 papers), Renal Diseases and Glomerulopathies (3 papers) and Inflammasome and immune disorders (3 papers). Eva-Maria Nichols collaborates with scholars based in United Kingdom, United States and Netherlands. Eva-Maria Nichols's co-authors include Gloria López‐Castejón, Daniel M. Davis, Fatima Martín‐Sánchez, Yu Shi, David Brough, Kevin J. Marchbank, Isabel Y. Pappworth, Matthew C. Pickering, Neil Sheerin and Thomas Barbour and has published in prestigious journals such as Kidney International, Frontiers in Immunology and Oncotarget.

In The Last Decade

Eva-Maria Nichols

11 papers receiving 242 citations

Peers

Countries citing papers authored by Eva-Maria Nichols

Since Specialization

Citations

This map shows the geographic impact of Eva-Maria Nichols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva-Maria Nichols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva-Maria Nichols more than expected).

Fields of papers citing papers by Eva-Maria Nichols

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva-Maria Nichols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva-Maria Nichols. The network helps show where Eva-Maria Nichols may publish in the future.

Co-authorship network of co-authors of Eva-Maria Nichols

This figure shows the co-authorship network connecting the top 25 collaborators of Eva-Maria Nichols. A scholar is included among the top collaborators of Eva-Maria Nichols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva-Maria Nichols. Eva-Maria Nichols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	C5aR2 Regulates STING-Mediated Interferon Beta Production in Human Macrophages 2023 ·Cells ·(unknown), (unknown), (unknown), You Zhou, (unknown), (unknown), (unknown), Luke O'neill, Kathy Triantafilou, Eva-Maria Nichols, Lee M. Booty	3
2	Mathematical Modeling of Complement Pathway Dynamics for Target Validation and Selection of Drug Modalities for Complement Therapies 2022 ·Frontiers in Pharmacology ·(unknown), Eva-Maria Nichols, Daniel P. Howsmon, (unknown), (unknown), Fraser Cunningham, (unknown), (unknown), Valeriu Damian	7
3	Complement membrane attack complex is an immunometabolic regulator of NLRP3 activation and IL-18 secretion in human macrophages 2022 ·Frontiers in Immunology ·(unknown), Joseph Kozole, Rachel E. Heap, (unknown), (unknown), Francesca Zappacosta, Roland S. Annan, N. W. Galwey, Eva-Maria Nichols, Louise K. Modis, Martha Triantafilou, Kathy Triantafilou, Lee M. Booty	8
4	Discovery of functionally distinct anti-C7 monoclonal antibodies and stratification of anti-nicotinic AChR positive Myasthenia Gravis patients 2022 ·Frontiers in Immunology ·(unknown), Wioleta M. Zelek, David J. Gower, Claus Spitzfaden, (unknown), (unknown), Lasse Stach, (unknown), Andrew Sanderson, Angela Bridges, (unknown), (unknown), (unknown), Richard G. Priest, Trevor Wattam, (unknown), Maria Feeney, (unknown), B. Paul Morgan, Eva-Maria Nichols	8
5	Internalization of the Membrane Attack Complex Triggers NLRP3 Inflammasome Activation and IL-1β Secretion in Human Macrophages 2021 ·Frontiers in Immunology ·(unknown), Jonathan D. Worboys, Fatima Martín‐Sánchez, (unknown), Ashley Ambrose, Gillian M. Tannahill, Eva-Maria Nichols, Gloria López‐Castejón, Daniel M. Davis	22
6	Novel Selection Approaches to Identify Antibodies Targeting Neoepitopes on the C5b6 Intermediate Complex to Inhibit Membrane Attack Complex Formation 2021 ·Antibodies ·Lasse Stach, (unknown), (unknown), Ryan P. Bingham, (unknown), Jo L. Bramhall, Adam Taylor, (unknown), (unknown), Claire L. Harris, Maria Feeney, Jane P. Hughes, Armin Sepp, Thil Batuwangala, (unknown), Eva-Maria Nichols	1
7	Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro 2020 ·Frontiers in Immunology ·(unknown), Yu Shi, Fatima Martín‐Sánchez, (unknown), Eva-Maria Nichols, Daniel M. Davis, David Brough, Gloria López‐Castejón	110
8	Mathematical Modelling of Alternative Pathway of Complement System 2020 ·Bulletin of Mathematical Biology ·Suruchi Bakshi, Fraser Cunningham, Eva-Maria Nichols, Marta Biedzka-Sarek, (unknown), (unknown), (unknown), (unknown), L. A. Peletier, Stefano Zamuner, Piet H. van der Graaf	9
9	Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients 2016 ·Immunobiology ·Christoph Q. Schmidt, (unknown), Eva-Maria Nichols, Mario Hebecker, Markus Anliker, Britta Höchsmann, Thomas Simmet, (unknown), Barbara Uzonyi, Isabel Y. Pappworth, Daniel Ricklin, John D. Lambris, Hubert Schrezenmeier, Mihály Józsi, Kevin J. Marchbank	24
10	An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy 2015 ·Kidney International ·Eva-Maria Nichols, Thomas Barbour, Isabel Y. Pappworth, Edwin Wong, Jeremy M. Palmer, Neil Sheerin, Matthew C. Pickering, Kevin J. Marchbank	50
11	A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL 2015 ·Oncotarget ·Eva-Maria Nichols, Rachel Jones, (unknown), Chris Pepper, Chris Fegan, Kevin J. Marchbank	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact